|
|
Volumn 18, Issue 24, 2000, Pages 4009-4015
|
|
Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOROURACIL;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT INTERLEUKIN 2;
ADULT;
AGED;
ARTICLE;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
FEMALE;
FEVER;
GASTROINTESTINAL DISEASE;
HEART DISEASE;
HEMATOLOGIC DISEASE;
HUMAN;
HYPOTENSION;
INFECTION;
KIDNEY CARCINOMA;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
MUCOSA INFLAMMATION;
MULTICENTER STUDY;
NEUROLOGIC DISEASE;
PRIORITY JOURNAL;
RANDOMIZATION;
SKIN DISEASE;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, RENAL CELL;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
ENDPOINT DETERMINATION;
FEMALE;
FLUOROURACIL;
HUMANS;
INFUSIONS, INTRAVENOUS;
INJECTIONS, SUBCUTANEOUS;
INTERFERON ALFA-2A;
INTERLEUKIN-2;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
SURVIVAL RATE;
|
|
EID: 0034671326
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1016/S1078-1439(01)00164-8 Document Type: Article |
|
Times cited : (132)
|
|
References (34)
|
